[Federal Register Volume 60, Number 14 (Monday, January 23, 1995)]
[Notices]
[Page 4425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1561]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:
Name of SEP: Clinical Trial to Evaluate the Prevention of Events
with Angiotensin Converting Enzyme Inhibitor Therapy (PEACE).
Date: February 7-8, 1995.
Time: 7:30 p.m.
Place: Holiday Inn, Bethesda, Maryland.
Contact Person: Anthony M. Coelho, Jr., Ph.D., 5333 Westbard
Avenue, Room 548, Bethesda, Maryland 20892, (301) 594-7485.
Purpose/Agenda: To review and evaluate contract proposals.
Name of SEP: SCOR in Transfusion Medicine and Biology.
Date: March 15-16, 1995.
Time: 7:00 p.m.
Place: Holiday Inn, Bethesda, Maryland.
Contact Person: Deborah P. Beebe, Ph.D., 5333 Westbard Avenue,
Room 555, Bethesda, Maryland 29892, (301) 594-7418.
Purpose/Agenda: To review and evaluate grant applications.
These meetings will be closed in accordance with the provisions set
forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications
and/or proposals and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and personal
information concerning individuals associated with the applications
and/or proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health.)
Dated: January 13, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-1561 Filed 1-20-95; 8:45 am]
BILLING CODE 4140-01-M
